A California-based biotech company found a tremendous amount of success on Tuesday following the company announcing an agreement to divest its Udenyca franchise for $558.4...

To read the full story on AllPennyStocks.com, click here.

Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Coherus BioSciences Charts.
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Coherus BioSciences Charts.